Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases
Biopharmaceutics & Drug Disposition · 2026
DOI: 10.1002/bdd.70021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biopharmaceutics & Drug Disposition, 2026. Verfasst von Rupsikha Kalita und 4 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Drug Delivery Laboratory, Department of Pharmaceutics, School of Pharmaceutical Sciences, Girijananda Chowdhury University, Guwahati, India. Hauptthemen laut MEDLINE: Curcumin, Neurodegenerative Diseases, Brain, Neuroprotective Agents. Die Arbeit nennt 154 Literaturangaben.
Abstract (Originalsprache)
Neurodegenerative diseases are progressive disorders that damage and eventually kill neurons in the central nervous system (CNS). In recent years, various research has been done on reliable and effective treatment methods for the most common neurodegenerative diseases such as Parkinson's, Alzheimer, and Migraine diseases. Different neurodegenerative disorders such as Huntington's disease, Alzheimer's disease, Parkinson's disease, amyotrophic, Lewy body disease can be treated by curcumin, which is a strong antioxidant polyphenol with neuroprotective and anti‐amyloid properties. However, Blood‐brain barrier (BBB) and blood cerebrospinal fluid barrier restricts the permeation of curcumin to the brain leads poor distribution of the drug in brain tissue. The intranasal pathway holds promise for enhancing the treatment of CNS disorders since it bypasses the BBB and increases the brain bioavailability of drug. As nanotechnology continues to improve, research on the delivery of drug through intranasal route has grown significantly in last 10 years. Several nanocarriers have been developed such as nano‐emulsions, microspheres, dendrimers, liposomes, carbon‐based nanoformulation, and nanoparticles to deliver curcumin to the brain via intranasal route for the treatment of neurodegenerative diseases. This study provided a thorough analysis of several curcumin nano‐formulations used in intranasal pathway as a novel treatment for neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advanced Drug Delivery Laboratory, Department of Pharmaceutics, School of Pharmaceutical Sciences, Girijananda Chowdhury University, Guwahati, India.
- Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India.
- Department of Pharmacology, NEF College of Pharmacy, Guwahati, India.
ORCID-Profile: Anupam Sarma
Zitieren
APA
Kalita, R., Sarma, A., Baruah, H., Zaman, A., & Goswami, D. (2026). Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.70021
Vancouver
Kalita R, Sarma A, Baruah H, Zaman A, Goswami D. Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases. Biopharmaceutics & Drug Disposition. 2026. doi:10.1002/bdd.70021
BibTeX
@article{Kalita2026,
author = {Kalita, Rupsikha and Sarma, Anupam and Baruah, Himakshi and Zaman, Asifa and Goswami, Deepjyoti},
title = {Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases},
journal = {Biopharmaceutics & Drug Disposition},
year = {2026},
doi = {10.1002/bdd.70021}
}
EUVIMED